Validation of 24-hour ambulatory gait assessment in Parkinson's disease with simultaneous video observation

BioMedical Engineering Online

Volumn 10, Issue , 2011, Pages

  Moore, Steven T ^a   Dilda, Valentina ^a   Hakim, Bandar ^a   MacDougall, Hamish G ^b  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF SYDNEY   (Australia)

Author keywords

Accelerometry; Levodopa; Motor fluctuations; Parkinsonian; Stride length

Indexed keywords

ACCELEROMETRY; LEVODOPA; MOTOR FLUCTUATIONS; PARKINSONIAN; STRIDE LENGTH;

ACCELEROMETERS; MONITORING;

NEURODEGENERATIVE DISEASES;

PARKINSONIA;

LEVODOPA;

ACCELERATION; AGED; AMBULATORY MONITORING; ARTICLE; FEMALE; GAIT; HUMAN; MALE; METHODOLOGY; PARKINSON DISEASE; PATHOPHYSIOLOGY; VALIDATION STUDY;

ACCELERATION; AGED; FEMALE; GAIT; HUMANS; LEVODOPA; MALE; MONITORING, AMBULATORY; PARKINSON DISEASE;

EID: 80053173984     PISSN: 1475925X     EISSN: 1475925X     Source Type: Journal    
DOI: 10.1186/1475-925X-10-82     Document Type: Article

References (18)

1. Poewe W, Antonini A, Zijlmans JC, Burkhard PR, Vingerhoets F. Levodopa in the treatment of Parkinson's disease: an old drug still going strong. Clin Interv Aging 2010, 5:229-238. 2938030, 20852670.
2. McColl CD, Reardon KA, Shiff M, Kempster PA. Motor response to levodopa and the evolution of motor fluctuations in the first decade of treatment of Parkinson's disease. Mov Disord 2002, 17:1227-1234. 10.1002/mds.10244, 12465061.
3. Nutt JG. On-off phenomenon: relation to levodopa pharmacokinetics and pharmacodynamics. Ann Neurol 1987, 22:535-540. 10.1002/ana.410220415, 3324948.
4. Brown RG, MacCarthy B, Jahanshahi M, Marsden CD. Accuracy of self-reported disability in patients with parkinsonism. Arch Neurol 1989, 46:955-959.
5. Golbe LI, Pae J. Validity of a mailed epidemiological questionnaire and physical self-assessment in Parkinson's disease. Mov Disord 1988, 3:245-254. 10.1002/mds.870030309, 3193962.
6. Goetz CG, Stebbins GT, Blasucci LM, Grobman MS. Efficacy of a patient-training videotape on motor fluctuations for on-off diaries in Parkinson's disease. Mov Disord 1997, 12:1039-1041. 10.1002/mds.870120631, 9399233.
7. Fahn S, Elton RL, . members. Up Unified Parkinson's disease rating scale. Recent developments in Parkinson's disease 1987, 2:153-163. Florham park, NJ: Macmillan healthcare Information, Fahn S, Marsden CD, Goldstein M, Calne DB, 3098794, 21569273, members. Up.
8. Mitchell SL, Harper DW, Lau A, Bhalla R. Patterns of outcome measurement in Parkinson's disease clinical trials. Neuroepidemiology 2000, 19:100-108. 10.1159/000026244, 10686534.
9. Clarke CE, Davies P. Systematic review of acute levodopa and apomorphine challenge tests in the diagnosis of idiopathic Parkinson's disease. J Neurol Neurosurg Psychiatry 2000, 69:590-594. 10.1136/jnnp.69.5.590, 1763425, 11032609.
10. van Hilten JJ, Middelkoop HA, Kerkhof GA, Roos RA. A new approach in the assessment of motor activity in Parkinson's disease. J Neurol Neurosurg Psychiatry 1991, 54:976-979. 10.1136/jnnp.54.11.976, 1014619, 1800670.
11. Hoff JI, van den Plas AA, Wagemans EA, van Hilten JJ. Accelerometric assessment of levodopa-induced dyskinesias in Parkinson's disease. Mov Disord 2001, 16:58-61. 10.1002/1531-8257(200101)16:1<58::AID-MDS1018>3.0.CO;2-9, 11215593.
12. Saito N, Yamamoto T, Sugiura Y, Shimizu S, Shimizu M. Lifecorder: a new device for the long-term monitoring of motor activities for Parkinson's disease. Intern Med 2004, 43:685-692. 10.2169/internalmedicine.43.685, 15468966.
13. Keijsers NL, Horstink MW, Gielen SC. Ambulatory motor assessment in Parkinson's disease. Mov Disord 2006, 21:34-44. 10.1002/mds.20633, 16127718.
14. Moore ST, MacDougall H, Gracies J-M, Cohen H, Ondo W. Long-term monitoring of gait in Parkinson's Disease. Gait Posture 2007, 26:200-207. 10.1016/j.gaitpost.2006.09.011, 17046261.
15. Moore ST, MacDougall H, Gracies J-M, Ondo W. Locomotor response to levodopa in fluctuating Parkinson's disease. Exp Brain Res 2008, 184:469-478. 10.1007/s00221-007-1113-y, 17828529.
16. Ondo WG, Shinawi L, Moore S. Comparison of orally dissolving carbidopa/levodopa (Parcopa) to conventional oral carbidopa/levodopa: A single-dose, double-blind, double-dummy, placebo-controlled, crossover trial. Mov Disord 2010, 25:2724-2727. 10.1002/mds.23158, 20925074.
17. Moore ST, MacDougall HG, Ondo WG. Ambulatory monitoring of freezing of gait in Parkinson's disease. J Neurosci Meth 2008, 167:340-348.
18. MacDougall HG, Moore ST. Marching to the beat of the same drummer: the spontaneous tempo of human locomotion. J Appl Physiol 2005, 99:1164-1173. 10.1152/japplphysiol.00138.2005, 15890757.